Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

NCT06238817 ·Status: COMPLETED ·Phase: PHASE3

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

NCT06718101 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

NCT04753034 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT04162899 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT06863961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

NCT04256174 ·Status: COMPLETED ·Phase: PHASE1

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

NCT03915496 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT04875169 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

NCT04086121 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

NCT03654755 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822 ·Status: COMPLETED ·Phase: PHASE3

Distribution of Tacrolimus in Skin, Atopic Dermatitis

NCT00534508 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

NCT06468956 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618 ·Status: RECRUITING ·Phase: PHASE3

A Study Evaluating APG777 in Atopic Dermatitis

NCT06395948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

NCT01756898 ·Status: COMPLETED ·Phase: PHASE2

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

NCT03822832 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470 ·Status: COMPLETED ·Phase: PHASE3

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

NCT07230860 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3